The median OPG levels were 1.7-fold higher in STEMI patients when compared to the no CAD group (2312.5 pg/mL ± 1418.9 pg/mL vs. 1396 pg/mL ± 816.5 pg/mL). The gene discussed is TNFRSF11B; the disease is coronary artery disorder.